Press releases | 2cureX

Press releases & news

2018-12-10

Press releases regulatory

2cureX is accelerating the launch of IndiTreat®

2cureX AB (“2cureX”) hereby announces that the clinical validation of IndiTreat® is running according to plan and that the company...

2018-11-23

Press releases regulatory

2cureX AB publishes interim report for January – September 2018

2cureX AB (”2cureX”) hereby publishes the interim report for the first nine months of 2018. The interim report is available...

2018-11-16

Press releases regulatory

The University Hospital, Vejle Hospital and 2cureX have received approval to start a clinical trial in pancreatic cancer

2cureX AB (“2cureX”) is pleased to announce that we together with our clinical partner Vejle Hospital have received approval to...

2018-10-09

Press releases regulatory

2cureX announces CE-IVD marking of its IndiTreat test

2cureX AB (“2cureX”), a leading company in conducting individual treatment design of cancer patients, is pleased to announce the receival...

2018-08-24

Press releases regulatory

2cureX AB publishes interim report for the first half-year of 2018

2cureX AB (”2cureX”) hereby publishes the interim report for the first half-year of 2018. The interim report is available via...

2018-08-22

Press releases regulatory

2cureX strengthen its patent portfolio with the granting of a new European patent

2cureX AB (“2cureX”) is pleased to announce the grant of European patent No. 3164709 “Identifying compounds modifying a cellular phenotype”....

Contact information

Laboratory: 2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint